Study Completed

Acne Vulgaris

Bayer Identifier:

Trial_ME93055

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Combined use of topical 20% azelaic acid cream (Skinoren) and oral antiandrogen (Diane-35) in the treatment of acne vulgaris.

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

16 - 36 Years

Trial summary

Enrollment Goal

131

Trial Dates

November 1993 - October 1994

Phase

Phase 2/3

Could I Receive a placebo

N/A

Products

Skinoren (Azelaic Acid, BAY39-6251)

Accepts Healthy Volunteer

N/A

Trial design

An open, non controlled multicenter study on the combined use of topical 20% azelaic acid cream (Skinoren®) and oral antiandrogen (Diane-35®) in the treatment of acne vulgaris

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.